ITM receives drug master file for gallium generator

By staff writers

December 8, 2020 -- German radiopharmaceutical firm ITM Isotopen Technologien has been granted a drug master file by the U.S. Food and Drug Administration (FDA) for its GeGant germanium-68/gallium-68 generator.

As a result, those who are interested in developing new drugs for the U.S. market can refer to the drug master file and use GeGant in clinical tests for radiopharmaceuticals and in other settings, ITM said. GeGant will be produced and distributed for the U.S. market by ITM's longtime partner RadioMedix.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking